These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26517109)

  • 1. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rare tumours: a new heading in Bulletin du cancer].
    Massard C; Droz JP
    Bull Cancer; 2010 Sep; 97(9):1031-9. PubMed ID: 20813656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 5. [Challenges for clinical research on rare tumors in Europe].
    Blay JY
    Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
    Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
    Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
    Ray-Coquard I; Trama A; Seckl MJ; Fotopoulou C; Pautier P; Pignata S; Kristensen G; Mangili G; Falconer H; Massuger L; Sehouli J; Pujade-Lauraine E; Lorusso D; Amant F; Rokkones E; Vergote I; Ledermann JA;
    Eur J Surg Oncol; 2019 Jan; 45(1):67-74. PubMed ID: 29108961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
    Brown J; Naumann RW; Brady WE; Coleman RL; Moore KN; Gershenson DM
    Gynecol Oncol; 2018 Jun; 149(3):605-611. PubMed ID: 29699802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 10. A unifying strategy for clinical trials in rare urological malignancy.
    Nicholson S
    Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645
    [No Abstract]   [Full Text] [Related]  

  • 11. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience.
    Pashankar FD; Rodriguez-Galindo C; Pappo A
    J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focusing on rare diseases in China: are we there yet?
    Yang L; Su C; Lee AM; Bai HX
    Orphanet J Rare Dis; 2015 Nov; 10():142. PubMed ID: 26525984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical genomics in rare cancer.
    Abbas-Aghababazadeh F; Mo Q; Fridley BL
    Semin Cancer Biol; 2020 Apr; 61():1-10. PubMed ID: 31437624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.
    Mathoulin-Pélissier S; Pritchard-Jones K
    Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010.
    Brecht IB; Bremensdorfer C; Schneider DT; Frühwald MC; Offenmüller S; Mertens R; Vorwerk P; Koscielniak E; Bielack SS; Benesch M; Hero B; Graf N; von Schweinitz D; Kaatsch P
    Pediatr Blood Cancer; 2014 Jul; 61(7):1202-9. PubMed ID: 24585499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare cancers: Challenges & issues.
    Pillai RK; Jayasree K
    Indian J Med Res; 2017 Jan; 145(1):17-27. PubMed ID: 28574010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.
    Schott AF; Welch JJ; Verschraegen CF; Kurzrock R
    Semin Oncol; 2015 Oct; 42(5):731-9. PubMed ID: 26433554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research methods to change clinical practice for patients with rare cancers.
    Billingham L; Malottki K; Steven N
    Lancet Oncol; 2016 Feb; 17(2):e70-e80. PubMed ID: 26868356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare cancer trial design: lessons from FDA approvals.
    Gaddipati H; Liu K; Pariser A; Pazdur R
    Clin Cancer Res; 2012 Oct; 18(19):5172-8. PubMed ID: 22718862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.